earli
protect
mechan
host
infect
trauma
tissu
damag
compris
set
reaction
known
acut
phase
respons
apr
one
main
featur
hepat
product
acut
phase
protein
app
determin
app
provid
tool
evalu
inflammatori
respons
host
infect
bovin
respiratori
diseas
brd
one
import
caus
morbid
mortal
beef
dairi
calv
respiratori
diseas
multifactori
diseas
caus
varieti
aetiolog
agent
environment
husbandri
factor
impair
resist
predispos
calv
infect
involv
app
potenti
use
investig
complex
pathogenesi
brd
evalu
role
aetiolog
factor
howev
inform
synthesi
pattern
app
natur
brd
infect
calv
need
studi
experiment
infect
shown
app
good
properti
marker
respiratori
infect
calv
viral
bacteri
combin
challeng
howev
limit
data
avail
app
diseas
marker
spontan
brd
studi
mainli
conduct
evalu
potenti
app
individu
herd
health
diagnost
bovin
acut
phase
protein
app
lipopolysaccharid
bind
protein
lbp
serum
amyloid
saa
haptoglobin
hp
alpha
acid
glycoprotein
agp
evalu
inflammatori
marker
outbreak
bovin
respiratori
diseas
brd
caus
bovin
respiratori
syncyti
viru
brsv
calv
n
present
mild
moder
sign
respiratori
diseas
secondari
bacteri
infect
pasteurella
multocida
mycoplasma
dispar
major
speci
detect
tracheobronchi
lavag
sampl
concentr
saa
lbp
increas
week
highest
valu
week
decreas
week
outbreak
calv
high
hp
concentr
week
agp
concentr
rise
respiratori
diseas
higher
saa
lbp
hp
concentr
later
stage
brd
week
associ
low
brsvspecif
igg
product
suggest
calv
enhanc
inflammatori
respons
secondari
bacteri
infect
conclus
app
especi
saa
lbp
sensit
marker
respiratori
infect
may
use
explor
host
respons
respiratori
infect
clinic
research
elsevi
ltd
right
reserv
tool
veterinari
practic
wittum
et
al
young
et
al
found
bovin
app
haptoglobin
hp
limit
capac
diagnost
clinic
tool
brd
feedlot
cattl
later
hp
consid
use
identifi
beef
calv
brd
need
treatment
monitor
treatment
efficaci
wherea
serum
amyloid
saa
alpha
acid
glycoprotein
agp
found
use
marker
brd
feedlot
calv
bovin
respiratori
syncyti
viru
brsv
shown
primari
infecti
agent
caus
mild
sever
clinic
respiratori
diseas
brsv
infect
commonli
accompani
bacteri
infect
thu
outbreak
pneumonia
caus
brsv
give
good
opportun
character
time
relat
pattern
differ
app
evalu
inflammatori
marker
natur
occur
respiratori
infect
object
studi
investig
chang
four
bovin
app
saa
lipopolysaccharid
bind
protein
lbp
hp
agp
outbreak
brd
young
dairi
calv
addit
calv
retrospect
divid
two
group
base
brsvspecif
igg
product
high
low
differ
pattern
app
concentr
chang
compar
explor
host
respons
differ
group
group
holstein
friesian
calv
male
femal
helsinki
univers
suitia
research
farm
follow
weekli
period
start
week
week
manifest
first
clinic
sign
brd
age
calv
week
present
tabl
calv
initi
includ
studi
investig
effect
age
physiolog
concentr
app
bloodsampl
weekli
without
manipul
calv
hous
two
group
fenc
calv
no
one
rest
automat
milk
feed
system
one
nippl
fenc
milk
powder
free
access
water
silag
hay
wean
approxim
age
week
calv
move
group
fenc
older
calv
first
calv
wean
move
sampl
week
disappear
clinic
brd
sign
fenc
locat
close
proxim
experi
approv
local
ethic
committe
anim
experi
blood
sampl
taken
weekli
jugular
vein
plain
glass
tube
serum
separ
centrifug
frozen
portion
store
await
analysi
calv
clinic
examin
conjunct
blood
sampl
overal
clinic
score
calcul
accord
gglund
et
al
follow
rectal
temperatur
respiratori
rate
min
nasal
discharg
normal
serou
mucopurul
purul
lung
auscult
abnorm
sound
wheez
sound
cough
cough
occasion
sporad
cough
one
spontan
cough
demeanour
bright
mildli
depress
moder
sever
depress
tracheobronchi
lavag
tbl
sampl
taken
doubl
cathet
method
bengtsson
et
al
week
end
experiment
period
week
calf
restrain
assist
steril
plastic
doubl
cathet
insert
ventral
nose
duct
trachea
inner
cathet
push
silicon
plug
outer
cathet
far
possibl
lung
isoton
steril
salin
solut
ml
inject
cathet
aspir
immedi
tbl
sampl
ml
transfer
mycoplasma
media
rest
sampl
use
bacteri
examin
tbl
sampl
three
calv
week
could
investig
difficulti
perform
lavag
procedur
tbl
sampl
examin
bacteri
mycoplasma
growth
describ
autio
et
al
nest
rtpcr
method
describ
vilcek
et
al
use
detect
brsv
rtpcr
method
detect
bovin
corona
viru
bcv
elisa
kit
svanova
biotech
uppsala
sweden
use
detect
igg
antibodi
specif
brsv
parainfluenza
viru
bcv
serum
sampl
accord
manufactur
instruct
sampl
gener
correct
optic
densiti
cod
valu
nm
regard
posit
calv
retrospect
divid
two
brsv
igg
antibodi
respons
group
base
serum
antibodi
detect
lowrespons
group
detect
brsv
igg
week
serum
cod
valu
cutoff
point
cod
valu
week
n
highrespons
group
brsv
igg
respons
week
cod
valu
week
n
fig
serum
hp
determin
use
haemoglobinbind
assay
describ
makimura
suzuki
modif
tetramethylbenzidin
mgml
use
chromogen
serial
dilut
pool
bovin
acut
phase
serum
lyophil
store
aliquot
use
standard
assay
calibr
use
sampl
known
hp
concentr
provid
european
union
concert
action
standard
anim
app
number
haemolysi
visibl
sampl
saa
measur
commerci
avail
elisa
kit
phase
saa
assay
tridelta
develop
ltd
maynooth
co
kildar
ireland
accord
manufactur
instruct
measur
serum
lbp
commerci
multispeci
includ
cattl
elisa
kit
use
lbp
elisa
variou
speci
hycult
biotechnolog
uden
netherland
serum
agp
analys
use
commerci
radial
immunodiffus
kit
cattl
bovin
agp
tridelta
develop
ltd
maynooth
co
kildar
ireland
pulsedfield
gel
electrophoresi
pasteurella
multocida
isol
p
multocida
isol
grown
overnight
brainheart
infus
broth
difco
spark
md
usa
cell
ml
harvest
centrifug
wash
ml
piv
buffer
mm
trishcl
ph
nacl
cell
resuspend
ml
piv
mix
equal
volum
incert
agaros
cambrex
rockland
usa
dispens
plug
mould
biorad
richmond
ca
usa
bacteria
plug
lyse
describ
previous
lysi
plug
wash
ten
buffer
mm
trishcl
ph
mm
edta
ph
mm
nacl
slice
plug
digest
u
sali
restrict
enzym
roch
mannheim
germani
fragment
separ
seakem
gold
agaros
cambrex
rockland
usa
tbe
use
chefdr
iii
system
biorad
richmond
ca
usa
ramp
time
h
vcm
temperatur
salmonella
braenderup
xbaidigest
use
molecular
marker
restrict
fragment
pattern
isol
compar
visual
linear
randomintercept
model
use
explor
time
chang
serum
concentr
app
respiratori
diseas
outbreak
app
chang
calv
observ
period
differ
brsv
antibodi
respons
group
analys
use
contrast
everi
time
point
compar
previou
time
point
age
calv
begin
observ
period
treatment
two
calv
week
includ
predictor
model
firstord
autoregress
correl
structur
use
model
serial
correl
repeat
measur
within
calv
plot
empir
autocorrel
function
normal
residu
use
explor
adequaci
correl
matrix
model
assumpt
verifi
scatter
normal
plot
standard
residu
logarithm
transform
saa
lbp
agp
reciproc
transform
hp
use
age
differ
brsv
antibodi
respons
group
week
analys
use
twosampl
wilcoxon
signedrank
test
statist
analys
perform
use
nlme
packag
r
version
chang
time
point
clinic
score
calv
differ
brsv
antibodi
respons
group
analys
use
gener
linear
mix
model
glmm
fit
glimmix
procedur
pdf
document
glimmix
procedur
june
http
wwwsascomstatisticsdochtml
sasstat
sa
institut
inc
cari
nc
usa
softwar
poisson
distribut
use
respons
variabl
clinic
score
calf
includ
random
effect
correl
structur
use
model
serial
correl
repeat
measur
calv
present
sign
respiratori
diseas
diseas
week
three
calv
clinic
score
week
rectal
temperatur
calv
show
sign
brd
start
week
fig
clinic
diseas
becam
pronounc
week
tabl
clinic
score
calv
increas
week
p
week
p
clinic
score
decreas
week
p
differ
seen
pattern
clinic
sign
brsv
antibodi
respons
group
overal
mild
moder
clinic
respiratori
diseas
record
maxim
score
two
calv
treat
antibiot
day
base
clinic
evalu
week
calv
no
clinic
score
respect
tabl
calv
also
rel
high
hp
valu
time
gl
respect
fig
calv
seroneg
brsv
week
week
calv
becom
seroposit
cod
valu
fig
calv
seroneg
bcv
throughout
observ
period
antibodi
viru
present
calv
week
gradual
decreas
data
shown
brsv
found
five
calv
tbl
sampl
tabl
tbl
sampl
bcv
found
tbl
sampl
investig
p
multocida
isol
nine
six
calv
first
second
sampl
respect
least
everi
calf
tabl
calf
p
multocida
infect
week
increas
saa
lbp
concentr
week
mgl
mgl
respect
chang
seen
rang
mgl
mgl
subsequ
sampl
respect
hp
respons
calf
also
lowest
peak
clinic
score
tabl
avail
p
multocida
isol
n
sinc
isol
calf
store
analysi
ident
sali
restrict
pattern
data
shown
mycoplasma
dispar
found
tbl
sampl
except
one
calf
week
bacteri
speci
isol
middl
brd
outbreak
week
later
stage
week
tabl
mean
saa
lbp
concentr
calv
increas
week
p
decreas
week
p
mean
hp
concentr
calv
decreas
week
p
mean
agp
concentr
decreas
week
p
differ
initi
app
concentr
age
brsv
antibodi
respons
group
outbreak
brd
gener
app
pattern
chang
differ
antibodi
respons
group
calv
low
antibodi
respons
elev
concentr
week
fig
mean
saa
concentr
increas
low
antibodi
group
week
p
compar
high
antibodi
group
mean
concentr
decreas
mean
lbp
concentr
decreas
week
p
increas
week
p
low
antibodi
group
compar
highrespons
group
mean
concentr
increas
decreas
respect
saa
lbp
concentr
three
calv
low
antibodi
group
remain
elev
end
studi
week
fig
similar
differ
chang
pattern
antibodi
respons
group
seen
also
hp
concentr
low
antibodi
group
hp
concentr
increas
week
p
decreas
week
p
compar
highrespons
group
clear
chang
occur
except
two
high
valu
week
fig
chang
app
concentr
studi
give
holist
view
possibl
time
sequenc
hostpathogen
interact
spontan
brd
outbreak
dairi
calv
initi
caus
enzoot
pneumonia
outbreak
probabl
brsv
none
calv
matern
antibodi
brsv
outbreak
igg
antibodi
transfer
via
colostrum
calv
develop
mark
increas
antibodi
end
studi
period
brsv
found
tbl
sampl
half
calv
week
indic
key
role
viru
infect
outbreak
calv
expos
br
viru
probabl
around
time
first
sampl
obtain
four
day
week
sampl
one
older
calf
brought
back
veterinari
clinic
receiv
oper
umbil
hernia
calf
show
clinic
sign
brd
arriv
treat
antibiot
respiratori
diseas
caus
elev
app
major
calv
increas
valu
sensit
app
saa
lbp
week
highest
concentr
hp
week
also
emphas
twostag
natur
inflammatori
respons
first
inflammatori
reaction
reflect
increas
saa
lbp
concentr
week
probabl
respons
br
viru
subsequ
pronounc
elev
saa
lbp
especi
hp
like
sign
secondari
bacteri
infect
heegaard
et
al
report
biphas
respons
saa
hp
brsv
challeng
one
calf
possibl
caus
secondari
infect
pasteurella
avium
found
necropsi
studi
high
saa
respond
calv
viru
challeng
subsequ
hp
rise
medium
low
saa
respond
show
hp
respons
suggest
hp
respons
requir
profound
tissu
damag
like
occur
bacteri
infect
support
also
field
studi
humblet
et
al
hp
found
good
marker
detect
calv
brd
requir
antibacteri
antiinflammatori
treatment
studi
two
calv
treat
antibiot
week
higher
hp
concentr
time
synergist
effect
brsv
bacteria
observ
present
studi
bacteri
speci
involv
microbi
growth
tbl
sampl
taken
around
middl
outbreak
sampl
taken
clinic
manifest
tabl
p
multocida
like
respons
enhanc
respons
app
later
stage
brd
calf
p
multocida
infect
week
minor
increas
saa
lbp
concentr
week
increas
hp
concentr
lowest
clinic
respons
week
previou
studi
p
multocida
infect
relat
high
concentr
app
investig
saa
hp
lbp
agp
fibrinogen
calv
brd
knowledg
genet
divers
p
multocida
strain
bovin
respiratori
infect
limit
calv
studi
infect
p
multocida
week
week
least
five
occas
genotyp
isol
sali
restrict
analysi
effici
differenti
p
multocida
strain
bovin
respiratori
tract
pohjanvirta
person
commun
isol
ident
sali
band
pattern
indic
one
infect
strain
persist
throughout
studi
predomin
strain
describ
previous
suggest
increas
capac
caus
diseas
p
multocida
infect
clinic
diseas
week
seem
littl
effect
inflammatori
respons
support
find
allen
et
al
report
recolon
p
multocida
lower
respiratori
tract
calv
suffer
brd
treatment
antibiot
interestingli
pronounc
app
respons
seen
later
stage
brd
outbreak
connect
calv
lower
specif
igg
respons
initi
brsv
infect
calv
mark
antibodi
product
lower
concentr
app
week
app
respons
clinic
brd
differ
app
respons
pattern
could
explain
differ
onset
infect
howev
calv
group
similar
saa
lbp
clinic
respons
week
br
viru
find
week
compar
lowrespons
highrespons
group
tabl
similar
distribut
antibodi
respons
group
calv
two
fenc
one
nippl
automat
feeder
fenc
possibl
assist
quick
spread
viru
control
infect
confirm
calv
receiv
viru
infect
similar
dosag
time
result
suggest
initi
onset
infect
probabl
happen
rel
short
timefram
also
compar
bacteri
growth
detect
calv
group
tabl
thu
trigger
agent
secondari
infect
avail
neither
immatur
immun
system
younger
calv
similar
age
distribut
group
presenc
matern
antibodi
brsv
detect
igg
week
explain
one
possibl
explan
calv
lower
humor
immun
respons
brsv
unabl
effici
remov
viru
despit
inflammatori
respons
suscept
subsequ
secondari
bacteri
infect
calv
good
antibodi
product
contrast
effici
abl
mount
protect
inflammatori
respons
clear
viru
present
secondari
bacteri
infect
viral
antibodi
abl
protect
respiratori
epithelium
bacteri
adher
mechan
virus
alter
host
suscept
secondari
bacteri
infect
alter
environment
condit
suppress
respiratori
defenc
system
numer
complex
one
mechan
enhanc
adher
bacteria
virusinfect
respiratori
cell
due
viral
glycoprotein
express
bartelt
duncan
suggest
protein
receptor
need
adher
bacteria
treatment
cell
trypsin
reduc
bacteria
bind
glycoprotein
g
found
increas
neisseria
mening
bind
rsvinfect
human
epitheli
cell
weak
antibodi
respons
rsv
infect
note
children
low
product
protect
antibodi
glycoprotein
studi
antibodi
human
influenza
viru
protect
cell
streptococc
adher
support
hypothesi
earli
suffici
product
antibodi
viru
may
protect
calv
exacerb
bacteri
infect
howev
tcell
respons
along
product
specif
igg
iga
virusneutr
antibodi
also
import
role
immun
respons
brsv
infect
argu
sole
favour
specif
igg
product
sinc
measur
immun
function
present
studi
show
saa
lbp
sensit
marker
respiratori
infect
previou
studi
use
calv
farm
exactli
condit
show
age
affect
concentr
app
gener
concentr
saa
lbp
agp
highest
first
week
life
decreas
afterward
stabil
around
week
age
effect
explain
high
valu
saa
lbp
agp
week
decreas
chang
concentr
agp
week
saa
lbp
concentr
increas
time
indic
presenc
inflammatori
stimulu
effect
age
also
control
age
along
treatment
two
calv
statist
model
avoid
possibl
confound
effect
conclus
result
indic
app
use
tool
clinic
research
studi
differ
aspect
hostpathogen
interact
respiratori
diseas
calv
field
condit
sensit
marker
evalu
clinic
respons
especi
clinic
diseas
sever
studi
earli
increas
respons
viral
infect
mark
rise
secondari
bacteri
infect
even
mild
moder
clinic
sign
brd
present
make
saa
lbp
best
candid
purpos
time
parallel
measur
hp
respons
valuabl
improv
evalu
sever
inflamm
